Anticyclic citrullinated peptide antibodies in patients with mixed connective tissue disease

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Modern Rheumatology

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.3109/s10165-004-0325-2PMID 17143695
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.

  2003cited by this paper
• High diagnostic performance of ELISA detection of antibodies to citrullinated antigens in rheumatoid arthritis

  2003cited by this paper
• Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis.

  2003cited by this paper
• Anticitrullinated protein/peptide antibody and its role in the diagnosis and prognosis of early rheumatoid arthritis.

  2002cited by this paper
• Prevalence and clinical significance of anti-cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis

  2002cited by this paper
• The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis.

  2000cited by this paper
• In the rheumatoid pannus, anti‐filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum

  2000cited by this paper
• The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide.

  2000cited by this paper
• Anti-perinuclear factor compared with the so called “antikeratin” antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides

  1999cited by this paper
• The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

  1995cited by this paper
• The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.

  1993cited by this paper
• Characterisation of the rat oesophagus epithelium antigens defined by the so-called 'antikeratin antibodies', specific for rheumatoid arthritis.

  1993cited by this paper
• Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

  1993cited by this paper
• [Antikeratin antibodies in rheumatoid arthritis].

  1991cited by this paper
• Antikeratin antibodies in rheumatoid arthritis

  1991cited by this paper
• Revised criteria for the classification of rheumatoid arthritis.

  1990cited by this paper
• The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

  1988cited by this paper
• Autoantibodies to Nonhistone Nuclear Antigens

  1985cited by this paper
• A nuclear antigen associated with cell proliferation and blast-transformation : its distribution in synchronized cells

  1982influential reference
• Scleroderma and erosive polyarthritis: a disease entity?

  1982cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

  1980cited by this paper
• Mixed Connective Tissue Disease: A Subsequent Evaluation of the Original 25 Patients

  1980cited by this paper
• Preliminary criteria for the classification of systemic sclerosis (scleroderma).

  1980cited by this paper
• Anti-keratin antibodies in rheumatoid arthritis.

  1979cited by this paper
• Clinical features of the arthritis of mixed connective tissue disease.

  1978influential reference
• Mixed connective tissue disease: the spectrum of radiographic manifestations.

  1977cited by this paper
• Mixed connective tissue disease--clinical and radiological aspects of 20 cases.

  1977cited by this paper
• Frequency and clinical significance of antibodies to ribonucleoprotein in SLE and other connective tissue disease subgroups.

  1977cited by this paper
• A COMPUTER‐ASSISTED ANALYSIS OF 153 PATIENTS WITH POLYMYOSITIS AND DERMATOMYOSITIS

  1977cited by this paper
• Radiological features of mixed connective tissue disease and scleroderma--systemic lupus erythematosus overlap.

  1976cited by this paper
• Mixed connective tissue disease--an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA).

  1972cited by this paper
• Characteristics of a soluble nuclear antigen precipitating with sera of patients with systemic lupus erythematosus.

  1966cited by this paper
• New Serum Factor in Patients with Rheumatoid Arthritis: The Antiperinuclear Factor *

  1964cited by this paper

• Response to comments on "The phenotype of mixed connective tissue disease patients having associated interstitial lung disease" by Chevalier K et al. and Shih PC.

  2023cites this paper
• Towards Early Diagnosis of Mixed Connective Tissue Disease: Updated Perspectives

  2023cites this paper
• Joint and muscle inflammatory disease: A scoping review of the published evidence.

  2023cites this paper
• Comparative assessment of hepatitis C virus-related arthritis and rheumatoid arthritis: Relation to clinical, serologic and ultrasonographic characteristics

  2023cites this paper
• The Prevalence of Anticitrullinated Protein Antibodies in Older Poles—Results from a Population-Based PolSenior Study

  2022cites this paper
• Sharp-Syndrom (Mischkollagenose, mixed connective tissue disease) bei Kindern und Jugendlichen

  2021cites this paper
• Overview of Mixed Connective Tissue Disease in Adults

  2021cites this paper
• Combining Calcitonin and Procalcitonin and Rheumatoid Arthritis-Related Biomarkers Improve Diagnostic Outcomes in Early Rheumatoid Arthritis

  2021cites this paper
• Rheumatoid Factor and Anti-Cyclic Citrullinated Peptide Antibodies Levels in Chronic Viral Hepatitis (B&C)

  2021cites this paper
• Normas

  2020cites this paper
• Rheumatoid Arthritis

  2020cites this paper
• Arthritis in Idiopathic Inflammatory Myopathies

  2019cites this paper
• Mixed Connective Tissue Disease

  2019cites this paper
• Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy

  2018cites this paper
• Rheumatoid factor and anti-cyclic citrullinated peptide (anti-CCP) antibodies with hepatitis B and hepatitis C infection: Review.

  2017cites this paper
• Undifferentiated Connective Tissue Disease, Mixed Connective Tissue Disease, and Overlap Syndromes in Children

  2017cites this paper
• Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis

  2016cites this paper
• Articular manifestations in Japanese patients with polymyositis and dermatomyositis

  2015cites this paper
• Connectivite mixte ou syndrome de Sharp

  2015cites this paper
• Chapter 36 – Rheumatoid Arthritis

  2014cites this paper
• Anticyclic Citrullinated Peptide Antibodies in Rheumatoid and Nonrheumatoid Rheumatic Disorders: Experience with 1162 Patients

  2014cites this paper
• Mixed connective tissue diseases: new aspects of clinical picture, prognosis and pathogenesis.

  2014cites this paper
• The diagnosis and classification of mixed connective tissue disease.

  2014cites this paper
• Interpreting Studies of Diagnostic Accuracy

  2014cites this paper
• The significance of rheumatoid factor and anti-cyclic citrullinated peptide antibodies in systemic lupus erythematosus.

  2013cites this paper
• The frequency of antibodies against cyclic citrullinated peptides and rheumatoid factor in healthy population: a field study of rheumatoid arthritis from northern turkey

  2013cites this paper
• Clinical Course, Prognosis, and Causes of Death in Mixed Connective Tissue Disease

  2013cites this paper
• Clinical manifestations of mixed connective tissue disease

  2012cites this paper
• Evaluating hand in systemic sclerosis

  2012cites this paper
• Distinct phenotypes in mixed connective tissue disease: subgroups and survival

  2012cites this paper
• Case history of mixed connective tissue disease

  2011cites this paper
• Meta-analysis: diagnostic value of serum anti-mutated citrullinated vimentin antibodies in patients with rheumatoid arthritis

  2011cites this paper
• Comparison of Serum Levels of Anti Cyclic Citrullinated Protein 2 with Rheumatoid Factor for the Diagnosis of Rheumatoid Arthritis in Gaza Strip

  2010cites this paper
• Systematic Review: Accuracy of Anti–Citrullinated Peptide Antibodies for Diagnosing Rheumatoid Arthritis

  2010influential citation
• Anti-cyclic citrullinated peptide antibodies are not associated with familial Mediterranean fever

  2010cites this paper
• Genetic studies of the HLA locus in rheumatic diseases

  2010cites this paper
• 3．全身性硬化症・混合性結合組織病

  2010cites this paper
• Citrulline Dependence of Anti-Cyclic Citrullinated Peptide Antibodies in Systemic Lupus Erythematosus as a Marker of Deforming/Erosive Arthritis

  2009cites this paper
• Systemic Lupus Erythematosus as a Marker of Deforming / Erosive Arthritis Citrulline Dependence of Anti-Cyclic Citrullinated Peptide Antibodies in

  2009cites this paper
• [Hemophagocytic syndrome in late-onset SLE patients].

  2009cites this paper
• Clinical significance of anti-cyclic citrullinated peptide antibodies in Egyptian patients with chronic hepatitis C virus genotype IV infection

  2009cites this paper
• Anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with idiopathic inflammatory myopathy.

  2009cites this paper
• Identification and characterization of candidate genes in Rheumatoid Arthritis

  2009cites this paper
• Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases

  2009cites this paper
• Antibodies to Citrullinated Vimentin are a Specific and Sensitive Marker for the Diagnosis of Rheumatoid Arthritis

  2008cites this paper
• Antibodies to citrullinated proteins in arthritis: pathology and promise

  2008cites this paper
• Immunity to citrullinated proteins in rheumatoid arthritis.

  2008cites this paper
• Management of mixed connective tissue disease

  2008cites this paper
• Patients with pulmonary tuberculosis are frequently positive for anti-cyclic citrullinated peptide antibodies, but their sera also react with unmodified arginine-containing peptide.

  2008cites this paper
• Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis

  2008cites this paper
• Mixed connective tissue disease: what is behind the curtain?

  2007cites this paper
• PONTIFÍCIA UNIVERSIDADE CATÓLICA DO RIO GRANDE DO SUL PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA E CIÊNCIAS DA SAÚDE ÁREA DE CONCENTRAÇÃO: CLÍNICA MÉDICA PROBABILIDADE DE ARTRITE REUMATÓIDE A PARTIR DA TESTAGEM PARA FATOR REUMATÓIDE E ANTICORPOS ANTIPEPTÍDEO CITRULINADO CÍCLICO

  2005cites this paper
• Enfermedad mixta del tejido conectivo

  2005cites this paper
• Autoimmune disorders (SLE, MCTD & Overlap Syndrome): Vivid Presentation and Clinician Perspective

  year unknowncites this paper